Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...
Eating lots of vegetables and taking probiotic supplements could help to slow the growth of low-risk prostate cancer, a study ...
Major PartnerTyrepower employees across the country took the power back against prostate cancer this year, raising funds for ...
Company to invest in further research to strengthen clinical evidence ahead of medium-term U.S. launch with no further FDA approvals needed PERTH, Australia, Nov. 20, 2025 /PRNewswire/ -- Orthocell ...
New research suggests that a vegetable-rich diet alongside probiotics could help slow the advancement of low-risk prostate ...
A diet rich in vegetables and probiotics could help slow the growth of low-risk prostate cancer, a new study suggests. Researchers found that specially designed supplements and probiotics appeared to ...
Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and Ramsay Hospital Research Foundation ...
News Medical on MSN
Model Forecasts Prostate Cancer Mortality Risk
Prostate cancer is the second-leading cause of cancer death in American men.About 1 in 8 men will be diagnosed with prostate ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...
The 85-year-old singer says that his cancer was caught early and is "gone at the moment", and is calling for others to get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback